An assessment of erythroid response to epoetin (alpha) as a single agent versus in combination with granulocyte- or granulocyte-macrophage - colony-stimulating factor in myelodysplastic syndromes using a meta-analysis approach

Authors :: Mundle, Suneel
Lefebvre, Patrick
Vekeman, Francis
Duh, Mei Scheng
Rastogi, Ruchi
Source :: Cancer. Feb 15, 2009, Vol. 115 Issue 4, p706, 10 p.
Publication Year :: 2009

Subjects :: Myelodysplastic syndromes -- Care and treatment
Myelodysplastic syndromes -- Patient outcomes
Myelodysplastic syndromes -- Research
Erythrocytes -- Physiological aspects
Erythrocytes -- Research
Erythropoietin, Recombinant -- Dosage and administration
Erythropoietin, Recombinant -- Research
Granulocyte-macrophage colony stimulating factor -- Dosage and administration
Granulocyte-macrophage colony stimulating factor -- Research
Chemotherapy, Combination -- Patient outcomes
Chemotherapy, Combination -- Research
Health

Tools